HANSON & DOREMUS INVESTMENT MANAGEMENT – Abbott Laboratories Transaction History
HANSON & DOREMUS INVESTMENT MANAGEMENT portfolio value:
$1.17M
portfolio value
HANSON & DOREMUS INVESTMENT MANAGEMENT quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.38% | -46 shares | -150K | $96.76 | 12.13K |
| Q2 2022 | share | Decrease | -0.76% | -93 shares | -129K | $108.65 | 12.18K |
| Q1 2022 | share | Increase | +17.95% | 1.86K shares | -12K | $118.36 | 12.27K |
| Q4 2021 | share | Decrease | -1.03% | -108 shares | 223K | $141 | 10.40K |
| Q3 2021 | share | Decrease | -5.13% | -569 shares | 36K | $117.68 | 10.51K |
| Q2 2021 | share | Decrease | -29.98% | -4.74K shares | -691K | $115.05 | 11.08K |
| Q1 2021 | share | Decrease | -3.76% | -618 shares | 96K | $118.49 | 15.83K |
| Q4 2020 | share | Increase | +48.39% | 5.36K shares | 595K | $107.81 | 16.45K |
| Q3 2020 | share | Increase | +0.13% | 14 shares | 194K | $106.81 | 11.08K |
| Q2 2020 | share | Decrease | -40.56% | -7.55K shares | -458K | $89.39 | 11.07K |
| Q1 2020 | share | Increase | +65.80% | 7.39K shares | 494K | $76.84 | 18.62K |
| Q4 2019 | share | 0.00% | 0 shares | 36K | $84.23 | 11.23K | |
| Q3 2019 | share | Decrease | -5.71% | -680 shares | -62K | $80.81 | 11.23K |
| Q2 2019 | share | Increase | +10.81% | 1.16K shares | 142K | $80.92 | 11.91K |
| Q1 2019 | share | Decrease | -6.05% | -692 shares | 32K | $76.6 | 10.75K |
| Q4 2018 | share | Decrease | -1.90% | -222 shares | -28K | $68.98 | 11.44K |
| Q3 2018 | share | 0.00% | 0 shares | 147K | $69.69 | 11.66K | |
| Q2 2018 | share | Decrease | -40.22% | -7.84K shares | -460K | $57.68 | 11.66K |
| Q1 2018 | share | Increase | +63.10% | 7.55K shares | 486K | $56.4 | 19.51K |
| Q4 2017 | share | Decrease | -1.48% | -180 shares | 35K | $53.46 | 11.96K |
| Q3 2017 | share | Increase | +20.94% | 2.10K shares | 160K | $49.74 | 12.14K |
| Q2 2017 | share | Increase | +0.57% | 57 shares | 45K | $45.07 | 10.04K |
| Q1 2017 | share | Increase | +1.27% | 125 shares | 64.23K | $40.93 | 9.98K |
| Q4 2016 | share | 0.00% | 0 shares | -38.23K | $35.17 | 9.86K | |
| Q3 2016 | share | 0.00% | 0 shares | 29K | $38.48 | 9.86K | |
| Q2 2016 | share | Decrease | -2.58% | -261 shares | -35K | $35.55 | 9.86K |
| Q1 2016 | share | Increase | +5.92% | 566 shares | -6K | $37.6 | 10.12K |